Characteristics of DV-infected patients
| Characteristic . | Control (n = 22) . | Dengue (n = 36) . |
|---|---|---|
| Age, years | 30 (27-34) | 38 (27-45) |
| Gender, male | 9 (41%) | 20 (55.55%) |
| Platelet count, ×1000/mm3 | — | 113.5 (81.2-162.5) |
| Hematocrit, % | — | 43.5 (40.7-45.3) |
| Albumin, g/dL | — | 3.7 (3.5-4.0) |
| TGO/AST, IU/L | — | 68.5 (34.7-114.3) |
| TGP/ALT, IU/L | — | 72 (49-105.5) |
| Hemorrhagic manifestations* | — | 14 (38.88%) |
| Venous hydration | — | 9 (25%) |
| Secondary Infection | — | 23 (64%) |
| Mild dengue | — | 22 (61.11%) |
| Mild dengue with warning signs† | — | 12 (33.33%) |
| Severe dengue‡ | — | 2 (5.55%) |
| PCR positive | 21 | |
| DV-1 | 12 (57%) | |
| DV-2 | 1 (5%) | |
| DV-4 | 8 (38%) |
| Characteristic . | Control (n = 22) . | Dengue (n = 36) . |
|---|---|---|
| Age, years | 30 (27-34) | 38 (27-45) |
| Gender, male | 9 (41%) | 20 (55.55%) |
| Platelet count, ×1000/mm3 | — | 113.5 (81.2-162.5) |
| Hematocrit, % | — | 43.5 (40.7-45.3) |
| Albumin, g/dL | — | 3.7 (3.5-4.0) |
| TGO/AST, IU/L | — | 68.5 (34.7-114.3) |
| TGP/ALT, IU/L | — | 72 (49-105.5) |
| Hemorrhagic manifestations* | — | 14 (38.88%) |
| Venous hydration | — | 9 (25%) |
| Secondary Infection | — | 23 (64%) |
| Mild dengue | — | 22 (61.11%) |
| Mild dengue with warning signs† | — | 12 (33.33%) |
| Severe dengue‡ | — | 2 (5.55%) |
| PCR positive | 21 | |
| DV-1 | 12 (57%) | |
| DV-2 | 1 (5%) | |
| DV-4 | 8 (38%) |
Data are expressed as median (interquartile range) or number (%).
ALT, alanine aminotransferase; AST, aspartate aminotransferase; TGO, glutamic-oxalacetic transaminase; TGP, glutamic-pyruvic transaminase.
Gingival, vaginal, and/or gastrointestinal bleeding, petechiae, and purpura.
Abdominal pain or tenderness, persistent vomiting, clinical fluid accumulation, mucosal bleed, and/or increased hematocrit concurrent with rapid decrease in platelet count; according to WHO criteria.2
Severe plasma leakage, fluid accumulation with ascites (evidenced by ultrasonography), and/or severe bleeding (vaginal bleed and/or gastrointestinal bleed); according to WHO criteria.2